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Introduction
Biliary obstruction secondary to malignancy is a common
clinical problem. Primary carcinomas of the pancreas, am-
pulla of Vater, bile ducts or liver are frequently involved.
Rarely, biliary obstruction is due to non-Hodgkin’s lymphoma
(NHL).1 Obstructive jaundice in these patients usually presents
late in the course of the disease. In only 1% of patients with
NHL is obstructive jaundice the presenting sign of the disease.
NHL cases, in which obstructive jaundice occurs, are
histologically diffuse B cell lymphomas.2,3
Obstructive jaundice due to NHL is caused mainly by
enlarged lymph nodes compressing the biliary tree. The most
common site of obstruction is the liver hilum, followed by the
common bile duct (CBD) and peripancreatic area. Unlike
more common malignancies causing biliary obstruction, NHL
more readily responds to chemotherapy.2–5 Palliation of jaun-
dice and cure are possible, even without a biliary drainage
procedure.1
Burkitt’s lymphoma is a subtype of NHL. It is endemic,
non-endemic, or HIV-related. Unlike other forms of NHL,
Burkitt’s lymphoma presents as an extranodal disease. We
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present the case of a patient suffering from non-endemic
Burkitt’s lymphoma whose initial presenting symptom was
obstructive jaundice.
Case report
A 68-year-old man was admitted to the surgical department
for investigation of obstructive jaundice. He presented with
right upper quadrant abdominal pain, nausea and fatigue, all
of which started a week prior to his admission. He also com-
plained of decreased appetite, with no weight loss. The pa-
tient’s sclera and skin were jaundiced and, on abdominal
examination, a moderate right upper quadrant tenderness was
noted and a swollen gallbladder was palpated. The remainder
of the physical examination was unremarkable. There was no
history of hepatobiliary disease, smoking, alcohol consump-
tion or drug abuse. The patient had a prior history of
hypertension but, otherwise, did not suffer from any other
diseases.
Initial blood tests in the emergency room revealed a
bilirubin level of 10.2 mg/dL, with 7.9 mg/dL being direct.
Amylase, lactate dehydrogenase (LDH), liver transaminase,
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total and direct bilirubin levels actually continued rising to 30
mg/dL and 23 mg/dL, respectively. Three days  later, another
PTC was performed, with the insertion of another internal
stent (Figure 2). Again, despite this procedure, the jaundice
continued to progress and total and direct  bilirubin levels rose
to 35 mg/dL and 27 mg/dL, respectively. At this point, separate
biliary external–internal drainage of the right and left hepatic
ducts was performed, but almost no bile was collected in the
drains and there was no clinical or laboratory improvement.
Because of the patient’s clinical deterioration, extreme
hyperbilirubinemia and inadequate biliary drainage, pallia-
tive surgery was performed on the 19th day of admission. The
patient underwent a laparotomy under general anaesthesia,
and a malignant process involving the head of the pancreas
and hepatoduodenal ligament was found. A swollen gallblad-
der was removed to allow identification of the CBD within the
malignant infiltrate. A drain was inserted into the right biliary
system. Only small amounts of bile could be aspirated. The left
hepatic bile duct would not allow passage of a separate drain.
Still, intraoperative cholangiography demonstrated patency
of both biliary systems.
Following this operation, there was still no significant
biliary drainage. Bilirubin levels did not decrease. LDH, aspar-
tate aminotransferase, ALP and GGT values were 1,450 U/L,
160 U/L, 200 U/L, and 150 U/L, respectively. The patient
continued to deteriorate. He developed hepatic encephalopa-
alkaline phosphatase (ALP), and gamma-glutamyl transferase
(GGT) were all mildly to moderately elevated (425 U/L, 773
U/L, 150 U/L, 565 U/L, and 350 U/L, respectively). Complete
blood count was unremarkable. Carcinoembryonic antigen
(CEA) and CA19-9 levels, which were measured during his
hospitalization, were 1.2 ng/mL and 227 U/mL, respectively.
Abdominal ultrasound examination demonstrated a
thickened oedematous gallbladder wall, dilated intrahepatic
and extrahepatic biliary ducts, dilated CBD measuring 1.8 cm,
and a 4-cm hypoechoic mass caudal to the pancreas, which was
suspected to be a malignancy. An abdominal computed
tomography (CT) scan demonstrated a mass involving the
head of the pancreas and the portal hilum. The inferior vena
cava was compressed (Figure 1). The gallbladder was enlarged
with extremely thickened walls.
Following these findings, endoscopic ultrasound (EUS)
was performed. The mass in the head of the pancreas and
portal hilum was compatible with a cluster of enlarged lymph
nodes involving the CBD, superior mesenteric vein and portal
vein. EUS-directed fine needle aspiration was performed, but
cytology was inconclusive and did not prove malignancy.
At this stage, our assumption was that the patient was
suffering from a locally advanced and inoperable periampullary
tumour. We decided to offer the patient a palliative biliary
drainage procedure. Percutaneous transhepatic cholangio-
graphy (PTC) was performed on the 10th day of his admission.
An internal stent was inserted into the hepatic duct and CBD.
Following the procedure, the patient developed mild
pancreatitis. Furthermore, the jaundice did not recede, and
Figure 1. Huge peripancreatic mass involving the liver hilum.
Figure 2. Percuta-
neous drainage of
the common he-
patic duct showing
patency of the bil-
iary tree.
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thy and multiple organ failure. He died 5 days after operation,
on the 24th day of his admission.
The patient’s family refused an autopsy. Pathological ex-
amination of the gallbladder, which was removed during
surgery, revealed diffuse infiltration of large, atypical lym-
phoid cells with many mitoses, in a starry-sky pattern. The
infiltration involved the entire thickness of the gallbladder
wall and also extended to the adipose tissue around it. The cells
were immunohistochemically identified as B lymphocytes,
were positive to MPG assay, and over 95% of them had the Ki-
67 proliferative marker. A diagnosis of malignant Burkitt’s
lymphoma was made.
Discussion
Obstructive jaundice is a known manifestation of NHL. Few
possible mechanisms have been reported  to cause jaundice in
patients with NHL. Compression of bile ducts by the lympho-
matous mass is the most frequent cause, followed by tumor-
related haemolysis and malignant liver infiltration.4–8 Since
NHL-induced obstructive jaundice almost always occurs with
advanced disease, it is treated with systemic chemotherapy.
Most regimens include anthracyclines, and these usually
achieve clinical improvement and resolves the jaundice.1–3
Biliary drainage procedures are reserved only for secondary
infectious complications of the obstruction.9
Clinical and radiological criteria may help to differentiate
between lymphoma and other tumours. Clinical cues suggest-
ing Burkitt’s lymphoma include laboratory values of LDH and
uric acid. Both are proportional to the tumour bulk. Since
Burkitt’s lymphoma is a highly proliferative tumour, LDH
rises quickly without proportion to other deteriorating liver
functions. In our patient, LDH gradually rose from 773 to
1,743 U/L (normal, 220–450 U/L), while all other liver func-
tion tests, except bilirubin, did not continue rising. We wrong-
ly attributed this rise to the fact that LDH also rises secondary
to various other reasons, including pancreatitis.
Uric acid is usually high in Burkitt’s lymphoma owing to
the tumor’s high rate of cell proliferation and spontaneous
tumor lysis and necrosis. In our patient, uric acid was 9.6
mg/dL on admission, but levels gradually decreased to nor-
mal (4.2–8.0 mg/dL). Thus, uric acid did not contribute to the
diagnosis of Burkitt’s lymphoma.
Several radiological criteria have been suggested to aid in
the distinction between lymphoma and other periampullary
malignancies.10 Lymphomas are usually larger than 7 cm, they
have a homogeneous consistency without necrosis or calci-
fication, and there may be evidence of invasive extension into
contiguous structures. However, these criteria are not sensi-
tive or specific enough to establish the diagnosis, and a tissue
biopsy is necessary in all cases suspected of being lymphoma.
Burkitt’s lymphoma is different since it is an extranodal disease,
making the diagnosis even harder. In cases of lesions located in
the hepatic hilum or peripancreatic area, preoperative histo-
logical diagnosis remains a major problem.3 Biopsies can be
obtained under ultrasound or CT guidance, during endo-
scopic retrograde cholangiopancreatography or PTC, and even
during EUS. In our patient, none of the radiological criteria
suggesting lymphoma and mentioned above were evident.
The extreme thickening of the gallbladder wall did suggest an
infiltrating type of malignancy, such as gallbladder carcinoma,
cholangiocarcinoma or Burkitt’s lymphoma.11,12
Most NHL cases that develop obstructive jaundice are
histologically diffuse B cell lymphomas. Burkitt’s lymphoma
is a solid subtype of B cell tumours. The endemic type usually
occurs between the ages of 12 and 30 years. It constitutes about
40% of childhood NHL cases. Burkitt’s lymphoma is rare in
adults, where it is either non-endemic or HIV-related. Burkitt’s
lymphoma is characterized by chromosomal translocations
resulting in increased expression of c-myc, which causes un-
controlled cellular proliferation. There is a typical histopatho-
logical appearance of densely clustered, monomorphic, small
noncleaved cells, in a classic “starry sky” pattern. The cells are
positive for mature B lymphocyte markers, such as CD10,
CD19, CD20 and CD22.
Burkitt’s lymphoma is usually diagnosed by performing a
biopsy. With aggressive chemotherapy, cure rates of up to 90%
in the endemic type are possible.13 The non-endemic type in
adults is less responsive, but cure is still possible. The case
presented demonstrates the importance of considering NHL
and Burkitt’s lymphoma in the differential diagnoses of ob-
structive jaundice. Since we assumed that the patient was
suffering from a locally advanced periampullary carcinoma,
our therapeutic efforts were directed only towards the pallia-
tion of obstructive jaundice.
Had the diagnosis of lymphoma been made sooner, aggres-
sive chemotherapy would have been administered and, possibly,
the patient’s outcome would have been different. The fact that
repeated percutaneous and intraoperative attempts at drain-
age failed should have raised questions regarding our assumed
aetiology and mechanism of jaundice. Repeated failure to
alleviate the jaundice by drainage procedures should have
prompted the thought that the primary mechanism of jaun-
dice was due to hepatocellular pathology. We believe that in
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our case, the cause of the jaundice was secondary liver infiltra-
tion by the lymphoma, leading to fulminant hepatic failure,
although we have no pathological proof of this. The extensive
infiltration of the entire gallbladder wall, however, supports
this assumption. Although primary lymphoma of the liver is
rare, secondary involvement of the liver in patients with NHL
is common and occurs in as many as 50% of patients.14 Second-
ary lymphoma is often diffusely infiltrative and may be diffi-
cult to detect on CT.15
Our patient deteriorated rapidly, and perhaps his disease
was so advanced that even chemotherapy would not have
changed the course of his disease. Still, it is crucial that lym-
phoma be taken into consideration early in the management
of patients with malignant obstructive jaundice.
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